Define HIV, explain HIV workplace policy, and discuss the medical management of a patient with HIV and TB.

a) Define HIV
HIV stands for Human Immunodeficiency Virus. It is a retrovirus that attacks the body's immune system, specifically the CD4 T cells, which are crucial for fighting off infections. Over time, it can lead to Acquired Immunodeficiency Syndrome (AIDS) if left untreated.

b) Explain the HIV workplace policy
An HIV workplace policy aims to protect the rights of employees living with HIV and prevent discrimination. Key aspects include:

• Non-discrimination: Ensuring that employees with HIV are not discriminated against in hiring, promotion, or termination.
• Confidentiality: Protecting the privacy of an employee's HIV status.
• Reasonable accommodation: Providing necessary adjustments to work conditions to support employees living with HIV, where appropriate.
• Education and awareness: Promoting understanding and reducing stigma related to HIV in the workplace.
• Access to services: Facilitating access to prevention, treatment, care, and support services for employees.

c) Discuss the Medical Management of Mrs. Chibwali
Mrs. Chibwali has both Tuberculosis (TB) and HIV, which is a common co-infection. Medical management involves treating both conditions simultaneously, with careful consideration of drug interactions and timing.

• Anti-Tuberculosis Treatment (ATT): Initiate a standard multi-drug regimen for TB, typically involving drugs like isoniazid, rifampicin, pyrazinamide, and ethambutol. The duration is usually 6-9 months, depending on the specific regimen and drug susceptibility.
• Antiretroviral Therapy (ART): Initiate ART for HIV to suppress the viral load, improve immune function, and prevent opportunistic infections. The timing of ART initiation relative to ATT is crucial; generally, ART is started 2-8 weeks after initiating ATT, especially if the CD4 count is low, to reduce the risk of Immune Reconstitution Inflammatory Syndrome (IRIS).
• Drug Interaction Management: Rifampicin, a key TB drug, has significant interactions with many ART drugs, particularly protease inhibitors and non-nucleoside reverse transcriptase inhibitors. The ART regimen must be carefully selected to minimize these interactions, often requiring dose adjustments or alternative ART drugs.
• Monitoring: Regular monitoring of liver function tests, renal function, complete blood count, CD4 count, and HIV viral load is essential due to potential drug toxicities and to assess treatment efficacy.
• Nutritional Support: Address weight loss and provide nutritional counseling to support overall health and recovery.

d) Describe five (5) preventive strategies for HIV

1. Consistent and Correct Condom Use: Using male or female condoms correctly and consistently during sexual intercourse significantly reduces the risk of HIV transmission.
2. Pre-Exposure Prophylaxis (PrEP): HIV-negative individuals at high risk of acquiring HIV can take antiretroviral medication daily to prevent infection.
3. Post-Exposure Prophylaxis (PEP): Antiretroviral medication taken within 72 hours after potential exposure to HIV can prevent infection.
4. Voluntary Medical Male Circumcision (VMMC): For men in high-prevalence settings, VMMC reduces the risk of heterosexually acquired HIV infection by approximately 60%.
5. Prevention of Mother-to-Child Transmission (PMTCT): Providing antiretroviral therapy to HIV-positive pregnant women and their infants significantly reduces the risk of HIV transmission during pregnancy, childbirth, and breastfeeding.
6. Harm Reduction for People Who Inject Drugs: Providing sterile needles and syringes, and offering opioid substitution therapy, reduces HIV transmission among people who inject drugs.